Reilly Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Reilly Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$18K	Buy	81 +13	+19%	+$2.53K	﹤0.01%	590
2021 Q3	$12K	Sell	68 -16	-19%	-$3.12K	﹤0.01%	639
2021 Q2	$17K	Hold	84	–	–	﹤0.01%	588
2021 Q1	$18K	Buy	84 +32	+62%	+$7.03K	﹤0.01%	563
2020 Q4	$12K	Buy	52 +16	+44%	+$3.67K	﹤0.01%	602
2020 Q3	$10K	Hold	36	–	–	﹤0.01%	581
2020 Q2	$10K	Hold	36	–	–	﹤0.01%	592
2020 Q1	$9K	Buy	+36	New	+$8.26K	﹤0.01%	576
2019 Q2	–	Sell	-43	Closed	-$8K	–	1011
2019 Q1	$8K	Buy	43 +4	+10%	+$739	﹤0.01%	735
2018 Q4	$6K	Hold	39	–	–	﹤0.01%	736
2018 Q3	$8K	Hold	39	–	–	﹤0.01%	757
2018 Q2	$7K	Hold	39	–	–	﹤0.01%	758
2018 Q1	$6K	Buy	+39	New	+$6.37K	﹤0.01%	751
2016 Q4	–	Sell	-15	Closed	-$1K	–	902
2016 Q3	$1K	Hold	15	–	–	﹤0.01%	808
2016 Q2	$1K	Hold	15	–	–	﹤0.01%	775
2016 Q1	$1K	Buy	+15	New	+$1.36K	﹤0.01%	1136
2015 Q3	–	Sell	-100	Closed	-$12K	–	1394
2015 Q2	$12K	Hold	100	–	–	﹤0.01%	815
2015 Q1	$12K	Buy	+100	New	+$12K	﹤0.01%	808
2014 Q1	–	Sell	-180	Closed	-$13K	–	860
2013 Q4	$13K	Buy	+180	New	+$12.5K	﹤0.01%	482

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Reilly Financial Advisors's VRTX Position: Q4 2021 in Review

Reilly Financial Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q4 2021, buying an estimated $2.53K and bringing the position to 81 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Reilly Financial Advisors first reported a position in VRTX in Q4 2013 and has held it in 19 quarters since. 1,034 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Reilly Financial Advisors held 81 shares of Vertex Pharmaceuticals worth $18K as of Q4 2021.
Reilly Financial Advisors bought 13 Vertex Pharmaceuticals shares in Q4 2021, an estimated $2.53K.
Vertex Pharmaceuticals made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #590 holding.
Reilly Financial Advisors first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 19 quarters since.
1,034 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.